Wide Field OCTA in Diabetic Patients
According to the World Health Organization, over 830 million people are living with diabetes, a number that has consistently grown for decades. Early screening for diabetes-related changes is essential for effectively managing the condition and reducing the risk of serious complications, including those that affect retinal health.
The webinar “Wide Field OCTA in Diabetic Patients,” made possible by the Canon Medical Academy, will explore how wide field OCTA technology can support early detection of diabetic eye diseases.
Join us on December 19, 2024, at 7 pm (CET) / 6 pm (GMT) to gain insights from leading experts in retinal imaging and care.
Live Webinar | Wide Field OCTA in Diabetic Patients
This webinar will bring together experts in the field, including Prof. Tariq Aslam, Dr. Karolina Szarzanowicz, and Dr. Ali Erginay, to discuss the latest advancements in wide field OCTA for diabetic patients.
With real-world case presentations and a live Q&A session, attendees will gain practical tips and a deeper understanding of this innovative imaging modality.
Program
Certificate*
All delegates will receive a certificate of attendance.
With real-world case presentations and a live Q&A session, attendees will gain practical tips and a deeper understanding of this innovative imaging modality.
Program
- Wide Field OCTA: A New Frontier in Retinal Vascular Disease Management | Prof. Tariq Aslam
- Wide Field OCTA: Practical Applications and Cases from the Clinic | Dr. Karolina Szarzanowicz
- The Role of UWF OCTA in Diabetic Retinopathy | Dr. Ali Erginay
- Live Q&A moderated by Prof. Tariq Aslam
- Understand the value of wide field OCTA in imaging diabetic patients
- Gain insights into practical applications through real-world cases
- Learn tips for interpreting OCTA results in diabetic retinopathy
- Participate in the live Q&A to find answers to your questions
Certificate*
All delegates will receive a certificate of attendance.
* Note: The full name entered by joining the live webinar will be used to generate your name on the attendance certificate.
Speakers and Presentations
Speaker:
Prof. Tariq Aslam, MD, MA(Oxon), DM (Oxon), FRCSEd(Ophth), PhD
Professor of Ophthalmology and Interface Technologies, University of Manchester
Consultant Ophthalmologist, Manchester Royal Eye Hospital
Director, IOVS MSc Course
Manchester, UK
Presentation: Wide Field OCTA: A New Frontier in Retinal Vascular Disease Management
Wide field OCTA is a technology that has come to maturity in its potential to transform the assessment of retinal vasculature. This talk will introduce the technology, its foundations, and resulting images with notes on proper use and interpretation.
The speakers will examine the rationale for its use in vascular conditions such as diabetes in common clinical situations, and will also cover its research potential and ongoing work looking at its use for ocular and non-ocular disease investigations.
Discover More About the Moderator
Consultant Ophthalmologist, Manchester Royal Eye Hospital
Director, IOVS MSc Course
Manchester, UK
Presentation: Wide Field OCTA: A New Frontier in Retinal Vascular Disease Management
Wide field OCTA is a technology that has come to maturity in its potential to transform the assessment of retinal vasculature. This talk will introduce the technology, its foundations, and resulting images with notes on proper use and interpretation.
The speakers will examine the rationale for its use in vascular conditions such as diabetes in common clinical situations, and will also cover its research potential and ongoing work looking at its use for ocular and non-ocular disease investigations.
Speaker:
Dr. Karolina Szarzanowicz, MBChB
Foundation Doctor
Manchester Royal Eye Hospital
Manchester, UK
Presentation: Wide Field OCTA: Practical Applications and Cases from the Clinic
This presentation will highlight the use of wide field OCTA in patients with diabetic retinopathy
Discover More About the Speaker
Manchester Royal Eye Hospital
Manchester, UK
Presentation: Wide Field OCTA: Practical Applications and Cases from the Clinic
This presentation will highlight the use of wide field OCTA in patients with diabetic retinopathy
Speaker:
Dr. Ali Erginay, MD
Full-time Consultant Ophthalmologist
Lariboisiere Hospital
Paris, France
Presentation: The Role of UWF OCTA in Diabetic Retinopathy
It is already shown that OCTA allows the identification of early evidence of microvascular changes and provides a quantitative assessment of diabetic maculopathy.
With the arrival of UWF OCTA we have the possibility to assess the extent of retinal ischemia in the periphery better than fluorescein angiography.
Discover More About the Speaker
Lariboisiere Hospital
Paris, France
Presentation: The Role of UWF OCTA in Diabetic Retinopathy
It is already shown that OCTA allows the identification of early evidence of microvascular changes and provides a quantitative assessment of diabetic maculopathy.
With the arrival of UWF OCTA we have the possibility to assess the extent of retinal ischemia in the periphery better than fluorescein angiography.
Discover More About the Moderator and Speakers
Prof. Tariq Aslam, MD, MA(Oxon), DM (Oxon), FRCSEd(Ophth), PhD Prof. Tariq Aslam began his medical training at Oxford University and completed his medical retina fellowship at Moorfields Eye Hospital. His first research doctorate from Oxford University involved clinical trials in ophthalmic surgery, and a further PhD from Heriot-Watt University investigated technology applications in ophthalmology.
Both doctorate theses utilized his computer programming skills, and his most recent led to a prize for the best PhD across all University disciplines. His current research explores many clinical interests in the retina, including psychological aspects and the potential for computerized and technological enhancement of patient care, along with novel device development.
He has over 100 peer-reviewed publications (predominantly as lead author) and several patents, and serves as an investigator on multiple commercial studies as well as investigator-led studies. His research has led to a spin-out medical technology company with awards for social impact, which is his ultimate research goal.
Dr. Karolina Szarzanowicz, MBChB Dr Szarzanowicz graduated with distinction from the University of Sheffield in 2023, where she was president of the Ophthalmology Society. Currently, she is working as a Foundation Doctor in ophthalmology at Manchester Royal Eye Hospital.
She has been involved in research projects on uveitis and diabetic retinopathy management, which she presented at conferences such as BIPOSA and Euretina.
Dr. Ali Erginay, MD Dr. Ali Erginay is a full-time Senior Consultant Ophthalmologist at Lariboisière Hospital.
He graduated from the Paris6 medical faculty, and also holds a degree in computer science from the Bosphorous University in Istanbul, and he is specialized in vitreoretinal disorders (DR, retinal vasculopathies, age-related macular degeneration, and inflammatory diseases of the retina).
His research focuses especially on DR and he participates in different national and international clinical trials dealing with vascular diseases of the retina. He is also interested in computerized medical imaging techniques and telemedicine networks in the Paris region.
He is a member of the French Ophthalmology Society (SFO), the European Study Group on Diabetic Eye Complications (EASDEC), Euretina, the European Fluorescein Angiography Club (FAN Club), the European Society of Ophthalmology (SOE), the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO).
Disclaimers
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
